Fig. 1 · Structure

Documents & Downloads

Ammonium Glycyrrhizinate (AMGZ)

Cat. No. A10070 CAS 1407-03-0

Dehydrogenase inhibitor

Mono-ammonium glycyrrhizinate(AMGZ) is a unique product derived from Licorice root and has an extremely sweet taste.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
11-beta-hydroxysteroid dehydrogenases

Ammonium Glycyrrhizinate (AMGZ) Research Summary

This section summarizes 2 in vitro studies of Ammonium Glycyrrhizinate (AMGZ) from 1 published reference.

Ammonium Glycyrrhizinate (AMGZ) In Vitro Studies

In human gastric epithelial AGS cells, ammonium glycyrrhizinate preserved actin organization during hydrogen peroxide challenge and reduced cell-death readouts after exposure and recovery. Protection was incomplete in the cell-death experiment. These findings describe the authors’ prepared ammonium salt in a cultured-cell injury model; they do not establish a direct molecular target or clinical efficacy. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Actin organization after peroxide challenge in AGS cells

Cell-based study · Human gastric epithelial AGS cells obtained from ATCC; cultured-cell oxidative injury model. [1]

AG pretreatment preserved actin organization during peroxide exposure. The comparison compounds had little protective effect under their tested conditions. This microscopy experiment measures cytoskeletal morphology, not a biochemical target or a quantitative viability rescue.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
H2O2-induced disruption of actin organizationQualitative confocal microscopy AG (10–100 μg/mL) reduced disruption relative to peroxide plus vehicle; results reported as similar in three independent experiments. No numerical effect size extracted.[1]

Literature-Reported Treatment Conditions

Treatment concentration
AG 10, 50 or 100 μg/mL; H2O2 challenge 0.3 mM. Comparison compounds LG, ON, GC and GR were tested at 50 μg/mL.
Exposure duration
AG pretreatment for 30 min, then H2O2 exposure for 1 h at 37 °C.
Method
Cell-culture pretreatment followed by peroxide challenge and actin imaging.
Vehicle
DMSO stock solutions reported in Reagents; the peroxide-only comparison is labeled vehicle in Fig. 2B. Final vehicle concentration for this experiment is not specified.
Co-treatment
AG plus H2O2 is an injury-challenge condition. LG, ON, GC and GR were separate comparators, not coadministered with AG.
Reported limits
No quantitative image scoring or numerical rescue percentage reported for Fig. 2B. Final matched solvent concentration is unspecified; Fig. 2A has a range inconsistency outside the fixed 0.3 mM condition selected here.
Methods and source locations

Compound reported in the paper: Ammonium glycyrrhizinate; Compound label in the paper: AG

Evidence concerns the authors’ prepared material in cultured AGS cells; it does not validate Adooq material, lots, clinical activity or other glycyrrhizin salts.

Fig. 2B, p. 268; identity/Reagents/Cell Culture, p. 264; Actin Staining, p. 265; Results, p. 267

H2O2-induced disruption of actin organization: TRITC-phalloidin staining with confocal microscopy; DIC images provide corresponding cellular morphology. — Fig. 2B and caption, p. 268; Results, p. 267; Actin Staining of AGS Cells, p. 265

Peroxide-induced cell death following AG treatment and recovery

Cell-based study · Human gastric epithelial AGS cells; peroxide exposure followed by recovery in fresh medium. [1]

AG reduced peroxide-associated nuclear condensation/fragmentation and the PI DNA-content cell-death signal. Peroxide-only, AG-only and control groups were included. The result is partial protection in this cultured-cell design, with residual cell death in the combined-treatment group.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Cell death assessed by PI DNA-content flow cytometryRepresentative percentage and qualitative group direction Representative Fig. 8C labels: control 5.7%, H2O2 43.5%, AG 4.9%, H2O2 + AG 21.2%. These are individual representative distributions, not group means. Fig. 8D summarizes three independent experiments as mean ± SD.[1]

Literature-Reported Treatment Conditions

Treatment concentration
AG 50 μg/mL; H2O2 0.3 mM.
Exposure duration
Initial 1 h exposure, followed by washing and 12 h in fresh complete medium with 10% FBS. The caption states that the AG-treated group was re-treated with AG 50 μg/mL for 12 h.
Method
Initial AG, H2O2 or combined exposure, then wash/recovery; phase-contrast imaging, DAPI staining and PI-based flow cytometry.
Vehicle
Compounds were prepared as DMSO stocks; the final matched solvent concentration for Fig. 8 is not specified.
Co-treatment
AG with H2O2 challenge; not a drug-combination efficacy experiment.
Reported limits
Exact group-average cell-death percentages and SD are not transcribed because they are graphical. Fig. 8 caption does not specify a statistical test or P value for individual comparisons. The 30 min pretreatment in the actin experiment is not borrowed for this design. The caption does not separately spell out recovery dosing for each AG-containing group; its wording is retained without adding a schedule.
Methods and source locations

Compound reported in the paper: Ammonium glycyrrhizinate; Compound label in the paper: AG

Evidence concerns the authors’ prepared material in cultured AGS cells; it does not validate Adooq material, lots, clinical activity or other glycyrrhizin salts.

Fig. 8 and caption, p. 274; Results, pp. 271–272; Apoptosis Assay/Statistics, p. 267; identity and shared culture methods, p. 264

Cell death assessed by PI DNA-content flow cytometry: PI staining after permeabilization and flow cytometry; supporting DAPI nuclear morphology and phase-contrast images. No exact group means or SD inferred from bars. — Fig. 8A–D and caption, p. 274; Results, pp. 271–272; Apoptosis Assay and Statistics, p. 267

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 1407-03-0
Applications Dehydrogenase inhibitor
Formula C42H62O16.NH3
Molecular Weight 840
Synonyms AMGZ
SMILES
C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O)C)(C)C(=O)O.N

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 146 mg/mL (173.81 mM)
Water 4 mg/mL (4.76 mM)
Ethanol Insoluble

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Ammonium Glycyrrhizinate (AMGZ) Research References

  1. [1] Oh HM, Lee S, Park YN, et al. Ammonium glycyrrhizinate protects gastric epithelial cells from hydrogen peroxide-induced cell death. Experimental Biology and Medicine (2009). PMID: 19144869 DOI: 10.3181/0805-RM-178 Source material

Added to your cart

View Cart Checkout
Loading...